224.74
price down icon1.95%   -4.46
pre-market  Pre-mercato:  224.74  
loading
Precedente Chiudi:
$229.20
Aprire:
$228.49
Volume 24 ore:
2.01M
Capitalizzazione di mercato:
$44.78B
Reddito:
$271.58B
Utile/perdita netta:
$1.87B
Rapporto P/E:
26.35
EPS:
8.53
Flusso di cassa netto:
$3.63B
1 W Prestazione:
-6.26%
1M Prestazione:
-7.55%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
Value
$224.32
$228.79
Portata 52W:
Value
$215.30
$246.75

Cencora Inc Stock (COR) Company Profile

Name
Nome
Cencora Inc
Name
Telefono
(610) 727-7000
Name
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Name
Dipendente
46,000
Name
Cinguettio
Name
Prossima data di guadagno
2024-05-29
Name
Ultimi documenti SEC
Name
COR's Discussions on Twitter

Cencora Inc Stock (COR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-01-03 Iniziato Barclays Overweight
2023-12-14 Iniziato Wells Fargo Equal Weight
2023-03-31 Iniziato Citigroup Buy
2023-01-31 Ripresa Evercore ISI Outperform
2022-10-11 Aggiornamento BofA Securities Neutral → Buy
2022-08-22 Ripresa Morgan Stanley Equal-Weight
2022-07-11 Downgrade Evercore ISI Outperform → In-line
2022-06-07 Aggiornamento Deutsche Bank Hold → Buy
2022-05-26 Aggiornamento Barclays Equal Weight → Overweight
2022-04-12 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-04-01 Ripresa Credit Suisse Outperform
2021-03-12 Ripresa Evercore ISI In-line
2021-02-04 Aggiornamento Evercore ISI In-line → Outperform
2021-02-02 Aggiornamento Cowen Market Perform → Outperform
2021-01-06 Aggiornamento BofA Securities Underperform → Neutral
2021-01-06 Aggiornamento Credit Suisse Neutral → Outperform
2020-12-10 Downgrade Wells Fargo Equal Weight → Underweight
2020-12-03 Iniziato Mizuho Neutral
2020-08-06 Aggiornamento Raymond James Mkt Perform → Outperform
2020-07-15 Iniziato Barclays Underweight
2020-06-15 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-04-23 Ripresa Credit Suisse Outperform
2020-04-16 Downgrade Raymond James Outperform → Mkt Perform
2020-04-13 Downgrade Robert W. Baird Outperform → Neutral
2020-04-01 Aggiornamento JP Morgan Neutral → Overweight
2020-03-17 Aggiornamento Citigroup Neutral → Buy
2020-02-11 Downgrade BofA/Merrill Buy → Underperform
2020-02-07 Aggiornamento Robert W. Baird Neutral → Outperform
2019-09-12 Iniziato Deutsche Bank Hold
2019-07-10 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2019-04-11 Iniziato Guggenheim Buy
2019-04-10 Downgrade BofA/Merrill Buy → Underperform
2019-04-10 Downgrade Evercore ISI Outperform → In-line
2019-02-11 Downgrade JP Morgan Neutral → Underweight
2019-01-17 Iniziato UBS Buy
2018-12-10 Downgrade Jefferies Buy → Hold
2018-10-26 Downgrade RBC Capital Mkts Outperform → Sector Perform
2018-09-20 Iniziato Berenberg Buy
2018-07-17 Ripresa Stifel Hold
2018-04-09 Iniziato MoffettNathanson Buy
2018-03-12 Aggiornamento KeyBanc Capital Mkts Sector Weight → Overweight
2018-03-12 Aggiornamento Raymond James Mkt Perform → Outperform
2017-09-25 Iniziato JP Morgan Neutral
2017-09-22 Iniziato William Blair Outperform
Mostra tutto

Cencora Inc Azioni (COR) Dati Finanziari

Cencora Inc (COR) Reddito 2024

COR ha riportato un ricavo (TTM) di $271.58 miliardi per il trimestre terminato il 2023-12-31, un +12.31% salita anno su anno.
loading

Cencora Inc (COR) Reddito netto 2024

COR l'utile netto (TTM) è stato di $1.87 miliardi per il trimestre terminato il 2023-12-31, un +7.96% aumento anno su anno.
loading

Cencora Inc (COR) Flusso di cassa 2024

COR ha registrato un flusso di cassa disponibile (TTM) di $3.63 miliardi per il trimestre conclusosi con 2023-12-31, un +76.41% aumento anno su anno.
loading

Cencora Inc (COR) Utile per azione 2024

L'utile per azione (TTM) di COR è stato pari a $9.18 per il trimestre terminato il 2023-12-31, un +11.41% crescita anno su anno.
loading

Cencora Inc Azioni (COR) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
COLLIS STEVEN H
Chairman, President & CEO
Apr 16 '24
Option Exercise
89.58
10,754
963,343
295,842
COLLIS STEVEN H
Chairman, President & CEO
Apr 16 '24
Sale
237.48
10,754
2,553,860
285,088
Mauch Robert P.
Executive Vice President & COO
Apr 15 '24
Option Exercise
89.58
33,877
3,034,702
81,976
Mauch Robert P.
Executive Vice President & COO
Apr 15 '24
Sale
235.09
57,564
13,532,721
24,412
COLLIS STEVEN H
Chairman, President & CEO
Mar 19 '24
Option Exercise
89.58
10,755
963,433
295,843
COLLIS STEVEN H
Chairman, President & CEO
Mar 19 '24
Sale
240.21
10,755
2,583,459
285,088
Campbell Elizabeth S
Executive Vice President
Mar 18 '24
Sale
238.12
6,977
1,661,363
8,246
Clark Gina
Executive Vice President
Feb 13 '24
Sale
230.48
1,100
253,528
24,802
Walgreens Boots Alliance, Inc.
10% Owner
Feb 07 '24
Sale
235.41
4,212,395
991,639,907
26,277,561
GREENBERG LON R
Director
Jan 15 '24
Option Exercise
219.43
1,340
294,036
26,219
medical_distribution CAH
$102.98
price up icon 0.79%
medical_distribution MCK
$530.27
price down icon 0.16%
$68.60
price down icon 0.26%
$25.43
price down icon 0.08%
medical_distribution OMI
$24.51
price up icon 2.08%
Capitalizzazione:     |  Volume (24 ore):